Differences in T Cell Depletion and Intestinal Mucositis Explain Inconsistent Effects of NOD2/CARD15 Polymophisms in SCT

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 10, 2011, Pages 1421-1423

  Van Der Velden, W J F M ^a   Donnelly, J P ^a   Blijlevens, N M A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CASPASE RECRUITMENT DOMAIN PROTEIN 15; FLUDARABINE; IDARUBICIN; THYMOCYTE ANTIBODY;

ANTIGEN PRESENTING CELL; ENTERITIS; GENETIC RISK; GRAFT VERSUS HOST REACTION; HUMAN; INNATE IMMUNITY; INTESTINE INJURY; LETTER; MORTALITY; MUCOSA INFLAMMATION; MUCOSAL IMMUNITY; NONHUMAN; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; REDUCED INTENSITY CONDITIONING; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL TRANSPLANTATION; T CELL DEPLETION; TISSUE INJURY; WHOLE BODY RADIATION;

FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; NOD2 SIGNALING ADAPTOR PROTEIN;

EID: 80052970820     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.04.007     Document Type: Letter

References (16)

1. Penack O., Holler E., van den Brink M.R. Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors. Blood 2010, 115:1865-1872.
2. Mullally A., Ritz J. Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood 2007, 109:1355-1362.
3. Holler E., Rogler G., Herfarth H., et al. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GVHD following allogeneic stem cell transplantation. Blood 2004, 104:889-894.
4. Mayor N.P., Shaw B.E., Hughes D.A., et al. Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. J Clin Oncol 2007, 25:4262-4269.
5. Holler E., Rogler G., Brenmoehl J., et al. The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GVHD and complications following related and unrelated donor haematopoietic stem cell transplantation. Int J Immunogenet 2008, 35:381-384.
6. Nguyen Y., Al-Lehibi A., Gorbe E., et al. Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation. Blood 2010, 115:3625-3631.
7. Granell M., Urbano-Ispizua A., Arostegui J.I., et al. Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation. Haematologica 2006, 91:1372-1376.
8. van der Velden W.J.F.M., Blijlevens N.M., Maas F.M., et al. NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation. Bone Marrow Transplant 2009, 44:243-248.
9. van der Straaten H.M., Paquay M.M., Tilanus M.G., et al. NOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2011.
10. van der Velden W.J.F.M., Herbers A.H., Feuth T., et al. Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation. PLoS ONE 2010, 5:e15156.
11. Ferrara J.L., Levine J.E., Reddy P., Holler E. Graft-versus-host disease. Lancet 2009, 373:1550-1561.
12. Turner B.E., Kambouris M.E., Sinfield L., et al. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease. Transplantation 2008, 86:968-976.
13. Penack O., Smith O.M., Cunningham-Bussel A., et al. NOD2 regulates hematopoietic cell function during graft-versus-host disease. J Exp Med 2009, 206:2101-2110.
14. Zhang Y., Louboutin J.P., Zhu J., Rivera A.J., Emerson S.G. Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J Clin Invest 2002, 109:1335-1344.
15. Calcaterra C., Sfondrini L., Rossini A., et al. Critical role of TLR9 in acute graft-versus-host disease. J Immunol 2008, 181:6132-6139.
16. Herbers A.H., Feuth T., Donnelly J.P., Blijlevens N.M. Citrulline-based assessment score: first choice for measuring and monitoring intestinal failure after high-dose chemotherapy. Ann Oncol 2010, 21:1706-1711.